Gurnet Point Capital completed the acquisition of a minority stake in Naveris.

Gurnet Point Capital, a venture capital firm investing in life science and pharmaceutical companies, completed the acquisition of a minority stake in Naveris, a biotechnology company delivering innovations in cancer detection, drug development, and clinical trials. Financial terms were not disclosed.